LPAR3 and cancer: We also considered an updated version of the PRISM (profiling relative inhibition simultaneously in mixtures) assay of cancer cell sensitivity by pooling the data of 1,514 GPCR drugs tested against 906 cell lines (Figures 6D and 6E; see STAR Methods).